Why the study?
Does the self-reported Morisky score accurately identify nonadherence with chronic cardiovascular medications compared to prescription refill data in patients on ACE inhibitors or lipid-lowering agents?
Population
377 patients who had taken an angiotensin-converting enzyme inhibitor or lipid-lowering agent for at least 3…
Comparison
Self-reported Morisky medication adherence scale vs Prescription refill data over the previous 14…
Design
Cross-sectional
Follow-up
14 months (retrospective refill data)
Authors
Loading...
Clinicians should avoid sole reliance on Morisky scores for CV adherence screening; leaves open need for validated alternatives.
Does the self-reported Morisky score accurately identify nonadherence with chronic cardiovascular medications compared to prescription refill data in patients on ACE inhibitors or lipid-lowering agents?
The 4-item Morisky scale has limited utility as a standalone screening tool for cardiovascular medication nonadherence due to poor sensitivity, positive predictive value, and internal consistency.
Shalansky et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: